If you have early Parkinson's disease
What is the purpose of this study?
This study is being done to see if inosine, a research study medication, can help slow the progression of Parkinson's disease.
Can I participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions:Parkinson Disease, early stage, PD, inosine, PSG, Parkinson's study group
Age: Between 30 - 100 Years
Gender: Male or Female
Detail Study Description
- You will take inosine, a study medication, or a placebo (lookalike pill containing no medicine).
- Neither you nor the research study staff will know if you are taking the study medication or placebo.
- You will be asked to come to Cleveland Clinic 16 times over 25 months.
Placebo, Inosine, Inosine